Mutations in the IDH1 and IDH2 genes are commonly found in certain types of tumors (particularly in brain tumors known as gliomas) and result in the production of an oncometabolite called 2-hydroxyglutarate (2-HG). Here, IDH2 is linked to central nervous system cancer.